AGP Executive Report

Online Safety Push: Meghan Markle used Geneva’s Lost Screen Memorial to warn that social media algorithms can “shape” children toward eating disorders, citing cases of anorexia linked to harmful feeds. Streaming Business Model: Netflix says it will add an ad-supported tier in Ireland next year, expanding ads to 15 countries including Switzerland, with non-skippable ads typically around five minutes per hour. AI in Healthcare (Global Trial): An international study led by UCL/LSHTM reports AI can generate radiotherapy plans at international best-practice quality, helping close the workforce gap in low- and middle-income settings. CERN Funding Reality Check: CERN’s Future Circular Collider has scientific backing and feasibility approval, but the CHF15bn ($19bn) price tag is now the hard part in a “fracturing world.” Swiss Tech/Industry Watch: Swatch canceled some Audemars Piguet-Swatch sales after crowds surged, citing public safety. Ancient Discovery: Researchers say they’ve found Caedmon’s Hymn, the oldest surviving English poem, embedded in a medieval manuscript in Rome.

Online Safety Push: Meghan Markle used a Geneva appearance to urge WHO and global health leaders to treat child online protection as a public health issue, warning that AI and “attention at any cost” systems are accelerating harm across borders. Swiss Tech in Space: Switzerland’s “Smile” solar-storm satellite is set to launch May 19, with Swiss universities and firms building mission software and key hardware. E-Ink Meets Android: BOOX’s Go Gen 2 Lumi review spotlights a 10-inch Android e-paper tablet aimed at reading and notes, with strong hardware and a complex software experience. Health Tech Trials: Small studies at ESTRO 2026 suggest targeted radiotherapy can delay progression in metastatic breast cancer, and prostate cancer may be treatable in just two outpatient sessions with minimal added side effects. Ancient Discovery: Swiss archaeologists report an “extremely rare” 2,000-year-old charred Roman bread loaf found at Windisch. Culture Tech: Researchers in Ireland say they’ve identified the oldest surviving English poem, Caedmon’s Hymn, inside a digitized medieval manuscript in Rome.

Luxury Watch Chaos: Audemars Piguet x Swatch “Royal Pop” launches turned into crowd-control nightmares across India and beyond, with viral push-and-queue scenes and store openings cancelled after safety concerns. Border Tech Update: The UK is expanding e-gates for kids—starting July 8, children aged eight and nine can use facial-recognition gates (with height and adult-accompaniment rules) to cut summer border queues. Wearables AI Push: Swiss startup Mosaic raised $3.8M to build ultra-efficient “perception chips” aimed at real-time spatial awareness for smart glasses without heavy power draw. Public Health Watch: New attention is swirling around hantavirus persistence in semen after recent cruise-related cases, including a study involving Swiss researchers. Culture & Heritage: Researchers found the oldest surviving English poem, “Caedmon’s Hymn,” embedded in the main Latin text of a medieval manuscript in a Roman library. Swiss Business Education: IMD in Lausanne is seeing growing demand for family-business succession training as wealth transfers accelerate.

Wearables & AI Chips: Swiss startup Mosaic just raised $3.8M to build ultra-low-power “perception chips” aimed at smart glasses—real-time object recognition and scene understanding without GPU-level battery drain. Sports Tech in Zurich: FIFA’s World Cup VAR upgrade is getting real: 1,200 players are being 3D scanned to create photorealistic digital twins for faster, more precise offside calls. Cybersecurity: A reported Android 16 flaw may let malicious apps ignore VPN settings and leak IP info, with Google saying it only hits users who install harmful apps. AI Finance Shock: SoftBank’s OpenAI bet is paying off—profit surged to $12B+ as OpenAI-linked gains drive results. Switzerland Watch Culture: Swatch says some Audemars Piguet-Swatch sales were stopped worldwide due to crowd-safety concerns, including in Dubai. Health/Regulatory: AstraZeneca and Daiichi Sankyo’s Enhertu got FDA approval in the US for two new HER2-positive early breast cancer indications. Local Context: Switzerland’s data-centre boom is raising fresh water-stress worries as AI cooling demand accelerates.

Swiss Intelligence Openness: Switzerland has agreed to declassify archival files on Nazi Josef Mengele, the “Angel of Death,” after historians pushed for access—though the release date is still unclear. Privacy vs Convenience: A new report argues Google Drive and Gmail are convenient but come with privacy trade-offs, pushing readers toward a Swiss alternative. EV Reality Check: An MIT/ETH Zurich-led study finds electric cars are broadly cost-competitive and cut emissions in most situations, challenging common “EVs don’t work” claims. Biotech Dealmaking: Roche is buying PathAI for $750M upfront plus milestones, aiming to boost AI diagnostics and automate parts of pathology workflows. Oncology Update: AstraZeneca and Daiichi Sankyo’s ENHERTU® got new US approvals for two early breast-cancer settings. Data Sovereignty in Practice: Heathrow is expanding its Salesforce-powered AI agent after it reduced traveler calls, moving more support onto WhatsApp and digital channels.

Air Defense Reboot: Switzerland is reassessing its air-defense setup after the U.S. warned Patriot deliveries could slip again over Iran—pushing Bern to weigh European and other alternatives like Germany’s IRIS-T, Franco-Italian SAMP/T, Israel’s Arrow-3, and South Korea’s Cheongung II. Aviation & SAF: SWISS is partnering with Metafuels for priority access to e-SAF production as Europe’s synthetic fuel rules tighten toward 2030. AI in Customer Service: Heathrow is scaling a Salesforce-built AI agent (“Hallie”) that answers most traveler questions via WhatsApp and is now moving into its website and app. Identity & Access: A new study warns biometric verification is locking blind and low-vision people out of services, even as agencies crack down on AI fraud. Public Health Shock: Spiez Laboratory research suggests hantavirus genetic material can persist in semen for up to six years, raising transmission concerns. Swiss Tech Culture: A Swiss “Pokémon princess” claims a £90m card collection—sparking both hype and skepticism over how verifiable it is.

UK Politics Shock: Markets are reacting to a fresh Labour leadership scramble after Wes Streeting’s resignation and talk of Andy Burnham’s return, pushing up gilt yields and weighing on sterling. Border Tech: The UK is expanding passport e-gates for children aged eight and nine from July 8, aiming to cut summer queues and adding 1.5m automated entries a year. Health Scare With Swiss Link: A new study from Spiez Laboratory says hantavirus genetic traces can persist in semen for up to six years, raising pressure to update male survivor guidance. Finance Watch: Alphabet sold a record 576.5bn yen ($3.6bn) in yen bonds to fund AI capex, while carry trades are enjoying their best run in years as rate gaps pull investors back in. Switzerland Angle: Swiss finance industry career prospects research puts AI and geopolitics front and center, with the Iran conflict seen as a credibility test for the Swiss hub. Wealth Spotlight: The Sunday Times Rich List fuels a “UK exodus” narrative as billionaires and multimillionaires relocate, with tech and finance fortunes still climbing.

Hantavirus Update: The MV Hondius outbreak keeps widening, but the latest U.S. reports say no Americans have been confirmed infected so far, while dozens are still being monitored and quarantine rules tighten as health teams race to trace the Andes strain’s origin. Space Science: NASA’s James Webb Space Telescope and the COSMOS-Web team have released the most detailed cosmic web map ever, charting how galaxies formed a vast network across 13.7 billion years. Swiss Corporate Watch: Oculis confirmed AGM results in Zug, including the election of Gregory D. Perry to its board, while Lithium Argentina secured RIGI approval for Stage 2 expansion at Cauchari-Olaroz. Cyber & Privacy: Android 16 is under scrutiny after a reported VPN bypass that can leak traffic outside protected tunnels—Google reportedly marked it “won’t fix.” Cloud Infrastructure: Equinix expanded Fabric Geo Zones to enforce data residency at the network level across more markets. Streaming Ads: Netflix says its ad tier will expand to 15 more countries in 2027, including Switzerland.

Humanoid robots go big in Germany: UK startup Humanoid says it will integrate at least 1,000 humanoid robots at Schaeffler factories, with a deal pointing to up to 100,000 units over the next five years—an aggressive signal that factory automation is moving from pilots to scale. Identity security pressure stays high: A Sophos survey finds over 70% of organizations hit by identity-related breaches in the past year, with Switzerland topping the breach rate—credential theft and account takeovers remain the weak link. Healthcare biotech momentum: Swiss-linked research highlights gene-editing that corrected an inherited epilepsy mutation in mice, while other reports push host-directed approaches against antibiotic-resistant bacteria. Media keeps monetising attention: Netflix says its ad tier now reaches 250M monthly active viewers, up from 190M, as it leans harder into advertisers. Swiss angle in the background: Ahold Delhaize publishes tax transparency showing it paid major corporate tax in Switzerland despite having no shops there.

AI Finance & Markets: Amazon made its debut in Swiss franc debt with a record six-part bond sale worth about 3.25bn CHF (up to 25-year maturities), underscoring how its $200bn AI infrastructure push is pulling in global funding. Public Health Watch: The hantavirus cruise outbreak tied to the MV Hondius is still being mapped—so far at least 11 sick and 3 dead—with experts stressing it’s not behaving like COVID-19 and that rodent-to-human spread is the main driver. Swiss Tech & Industry: 908 Devices is buying Swiss AI spectroscopy firm NIRLAB AG to strengthen handheld narcotics detection, while SEALSQ positions its post-quantum and trusted-chip stack for secure “orbital” data centers. Policy Clash: California’s new plastic recycling rules are already triggering lawsuits and counter-suits, as producers argue the targets are unrealistic and advocates say they don’t go far enough. Health Tech: Gilead will present new EASL data on primary biliary cholangitis and viral hepatitis, adding to a busy week for pharma updates.

AI & Finance: SoftBank’s net profit more than tripled to $11.6B as it booked gains on its OpenAI stake, but the scale of the bet is reigniting questions about funding pressure and AI competition. Industrial AI & Automation: ABB is pushing two fronts—an IE6 magnet-free motor for hazardous areas (energy-loss cuts up to 60%) and an AI quality-control collaboration with Alcemy for cement and concrete. Biotech Moves: Anaveon appointed Thomas P. Mathers as board chair as it advances immunology programs; Vidac Pharma is in advanced talks to expand into Quest for Health in Strasbourg. Health Tech & Research: A study links higher vitamin K1 intake with lower COPD risk, while another reports home-based AI can flag early mobility decline in midlife adults. Policy & Society: Switzerland’s Science Council recommends a national AI infrastructure strategy, as WISeKey expands its HUMAN-AI-T push for ethical, human-governed AI. Public Safety Watch: The MV Hondius hantavirus outbreak keeps triggering quarantines and contact tracing across multiple countries.

Biometrics, but make it enforcement: ICE is buying nationwide access to a private iris database (5+ million booking records) via Bi2 Technologies, pushing real-time identity checks deeper into immigration operations. Fraud prevention shifts from “who” to “risk now”: Feedzai argues identity alone isn’t enough as instant payments and open banking speed up scams—so biometrics must become continuous, behavior-driven protection. Swiss health tech lands in Europe: Roche gets CE marking for Elecsys pTau217, a blood test aimed at earlier Alzheimer detection. Quantum in Colorado: IonQ opens a new Boulder R&D lab to scale trapped-ion systems and create dozens of jobs. Art meets surveillance themes: Art Basel’s Zero 10 names Trevor Paglen as Swiss curator for a digital-art program on “The Condition.” EV policy pressure: New Automotive pegs Europe’s EV push at ~€200B, but warns policy drift could waste investment and jobs.

Hantavirus Fallout: The MV Hondius outbreak keeps widening in real time: new Andes-strain cases have been reported in repatriation flights, with passengers placed in biocontainment and strict monitoring as officials try to map how far person-to-person spread may have gone. Swiss Tech & Sovereignty: Sunrise and PHOENIQS are pitching Swiss-only AI hosting for regulated firms—no data leaving Switzerland, aimed at finance, healthcare, public sector and energy. AI in Enterprise: Atos is teaming with Elastic to roll out Elasticsearch-based search and AI services across Europe, including Switzerland, as companies modernize data stacks. Aviation & Climate Math: Lufthansa ordered 20 long-haul jets worth $7.7bn to cut fuel burn and emissions, with deliveries starting in 2032. Digital Culture: Trevor Paglen will curate Art Basel’s Swiss “Zero 10” digital art sector, bringing investigative tech art to Basel’s June fair. Policy Mood: A new survey says climate disengagement and fatalism are rising in Switzerland despite visible warming. Pharma Moves: Novartis is expanding its India R&D and clinical development push toward advanced therapies.

Energy & Industry Push: ABB is pouring $200m into medium-voltage switchgear manufacturing across Europe to cut lead times and support data-center-driven power demand. Data Center Shock: NorthC’s Almere (near Amsterdam) site is still dealing with a fire that’s kept teams out while utilities and university systems report outages. AI Finance, Swiss Angle: Alphabet is weighing its first yen bond sale to fund AI infrastructure, following a big Swiss franc debut earlier this year—another sign debt markets are becoming part of the AI build-out. AI Policy Watch: The OECD’s AI recommendation is pushing member states toward “trustworthy AI” and a common approach to reporting AI incidents. Health & Travel Alert: The hantavirus cruise scare continues to dominate headlines, with U.S. passengers isolating in Nebraska and Atlanta as sequencing confirms the Andes strain. Swiss Science Spotlight: ETH Zurich-led work at BedrettoLab triggered thousands of controlled quakes to study fault behavior deep under the Alps. Tech Jobs: Cloudflare shares bounced after it said it will cut about 20% of staff as AI agents take on more work.

In the last 12 hours, the most clearly “tech-relevant” Swiss development is Roche’s deal to acquire US-based PathAI for $750 million upfront plus up to $300 million in milestones, building on a five-year partnership that scaled in 2024 to develop AI-enabled companion diagnostic algorithms. Roche frames the move as strengthening its position in digital pathology and automating workflows with AI, with expected closing in the second half of 2026. Separately, Swiss liquid-cooling company Corintis appointed liquid-cooling pioneer Geoff Lyon as President as its microfluidic direct-to-chip technology reaches commercial scale—an executive move aimed at scaling a core enabling technology for next-generation AI chips.

Also in the last 12 hours, Swiss digital-asset infrastructure continues to move from pilots toward regulated services: Amina Bank announced it will provide FINMA-supervised custody and trading for Canton Coin, positioning itself as the first regulated bank to offer custody and trading for the token tied to Canton Network. While the provided text is a mix of a TL;DR and a longer excerpt, the thrust is consistent: the bank is integrating custody/trading so institutional clients can operate under FINMA oversight, with the Canton network described as focused on finance tokenization and asset settlement.

Beyond Switzerland, the news cycle is dominated by a major public-health story that has immediate cross-border implications for Europe, including Switzerland. Multiple articles describe the hantavirus outbreak linked to the Dutch-flagged cruise ship MV Hondius, with WHO confirmation of an additional case in Zurich and reporting of eight cases linked to the outbreak (three lab-confirmed), alongside evacuations and ongoing investigations into origins and possible transmission routes. The evidence in the most recent material emphasizes escalation in Europe (including Switzerland) and continued uncertainty about how the outbreak is spreading.

Looking across the broader 7-day window, there is continuity in both the “AI/tech commercialization” theme and the “regulated infrastructure” theme. For example, earlier coverage includes Swiss Water’s quarterly results (industry context rather than a tech shift), and multiple items around AI-enabled platforms and modernization efforts (e.g., Temenos launches composable retail deposits/lending; Google Cloud/OTB’s AI virtual try-on—though not Swiss-specific). Meanwhile, the hantavirus coverage expands from initial outbreak reporting into deeper background on the Andes virus and prior outbreaks, reinforcing that the current European concern is part of a longer-running scientific and epidemiological challenge rather than a one-off incident.

Over the last 12 hours, the most clearly “tech-relevant” Swiss-linked items were regulatory and infrastructure moves rather than pure product launches. Crypto custodian Taurus received a MiFID II investment license in Cyprus, positioning it to offer MiFID-regulated services for tokenized financial instruments across the EU—an explicit attempt to bridge crypto-native custody with traditional capital-market compliance. In parallel, Temenos announced new Composable Retail Deposits and Composable Retail Lending offerings aimed at helping banks modernize core retail domains progressively via APIs and event-driven integration, reducing the disruption risk of full core upgrades. Switzerland also appears in the broader ecosystem through CARBOGEN AMCIS, whose Shanghai site completed an unannounced NMPA GMP inspection with no observations, reinforcing the company’s manufacturing compliance posture.

Health and science coverage also dominated the same window, with several items that connect to Swiss research capacity. A large randomized trial reported brolucizumab as superior to panretinal laser photocoagulation for preserving visual acuity in proliferative diabetic retinopathy, with the study author based at the University of Bern. Separately, a Swiss-relevant research thread linked DNA and language diversity: a University of Zurich-led study found that more genetically isolated populations tend to show greater structural diversity in languages, even after controlling for geography and other factors. While not “technology” in the commercial sense, both stories reflect Switzerland’s ongoing role in advanced biomedical and data-intensive research.

Geopolitics and risk conditions formed a second major theme in the last 12 hours, affecting markets and travel behavior. Coverage said the Iran war paused a global easing push by central banks in April, with multiple major central banks holding rates and oil-price dynamics feeding inflation expectations. That same uncertainty showed up in consumer-facing reporting: Americans are rethinking summer travel amid Iran-war concerns, with some postponing trips and shifting to domestic options. For Switzerland Tech Review readers, the takeaway is that even when the news is not directly about Swiss tech, the macro backdrop is shaping investment and demand conditions.

Beyond the most recent 12 hours, the continuity is visible in how regulation, modernization, and cross-border systems keep recurring. Earlier coverage included US legislation targeting universities that accept research funding from “hostile” countries—potentially affecting research ecosystems tied to areas like AI, biotech, and quantum. There was also continued emphasis on digital transformation in finance (e.g., Temenos-related modernization efforts) and on Switzerland’s broader innovation footprint (e.g., Swiss biotech sector resilience and other research/industry updates), though the provided older articles are more numerous than they are tightly clustered around a single Swiss tech development.

Note: The evidence in the last 12 hours is broad but not always Switzerland-specific; several items are global (EU licensing, US travel, central banks). The clearest Switzerland-linked signals in that window are the University of Bern trial leadership, University of Zurich research, and Swiss-based companies/announcements such as CARBOGEN AMCIS and Temenos.